Application of Plackett–Burman Screening Design for Formulation of Telmisartan Nanosuspension
Open Access
- 1 January 2025
- journal article
- Published by Uphills Publishers LLC in South Eastern European Journal of Public Health
- p. 2769-2774
Abstract
Developing formulations for medications with low water solubility and low oral bioavailabilitypresents significant challenges. Poor water solubility and a slow rate of dissolution are issuesfor the majority of newly developed and well-established biologically active compounds.Telmisartan (TM) is a BCS class-II medication characterized by low solubility as well as highpermeability. The current study set out to determine crucial formulation and processingcharacteristics that could affect the nanosuspension's quality. Using the nanoprecipitationultrasonication process, a poorly soluble medication was converted into a nanosuspension formulation. In order to screen five independent factors—the amount of stabilizer (mg) (X2), the amount of Telmisartan (mg) (X1), the volume ratio of solvent to anti-solvent (X3), the speed of stirring (RPM) (X4), and the sonication time (min) (X5)—a total of eight experiments werecreated. The dependent factors used were saturation solubility (μg/ml) and mean particle size(nm). The acquired results demonstrated that, in comparison to all other stabilizers, the nanosuspension made with Poloxamer 407 has improved saturation solubility. The amount oftelmisartan and the speed at which the mixture is stirred were also discovered to be potentialformulation and processing parameters that exert considerable influence on the quality of thetelmisartan nanosuspension.Keywords
This publication has 11 references indexed in Scilit:
- Ciprofloxacin surf-plexes in sub-micron emulsions: A novel approach to improve payload efficiency and antimicrobial efficacyInternational Journal of Pharmaceutics, 2011
- Engineering gas-foamed large porous particles for efficient local delivery of macromolecules to the lungEuropean Journal of Pharmaceutical Sciences, 2010
- Drug nanocrystals for the formulation of poorly soluble drugs and its application as a potential drug delivery systemJournal of Nanoparticle Research, 2008
- Nanosizing — Oral formulation development and biopharmaceutical evaluationAdvanced Drug Delivery Reviews, 2007
- p-Aminophenol degradation by ozonation combined with sonolysis: Operating conditions influence and mechanismUltrasonics Sonochemistry, 2007
- Drug nanocrystals of poorly soluble drugs produced by high pressure homogenisationEuropean Journal of Pharmaceutics and Biopharmaceutics, 2006
- Nanosuspensions as particulate drug formulations in therapyAdvanced Drug Delivery Reviews, 2001
- Absorption, Metabolism, and Excretion of Intravenously and Orally Administered [14C]Telmisartan in Healthy VolunteersThe Journal of Clinical Pharmacology, 2000
- The Effect of Telmisartan on the Steady‐State Pharmacokinetics of Digoxin in Healthy Male VolunteersThe Journal of Clinical Pharmacology, 2000
- Improvement of the in vitro dissolution characteristics of famotidine by inclusion in β-cyclodextrinInternational Journal of Pharmaceutics, 1990